Skip to main content
Screener/Healthcare/Biotechnology

QNCX Quince Therapeutics, Inc.

NASDAQ
$0.97+0.04 (+4.82%)
$0.79
$45.50
$0.90
$1.00
EPS (TTM)$-6.23
P/E Ratio-0.07
Dividend Yield
Market Cap$5.9M
Volume392K
Prev Close$0.93
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$0$35.9M$7.17
Q4 '25$0-$39.5M$-7.50
Q3 '25$0-$13.4M$-2.50
Q2 '25$0-$16.0M$-3.40
Q1 '25$0-$15.0M$-3.40
Q4 '24$0-$12.5M$-2.80
Q3 '24$0-$5.5M$-1.30
Q2 '24$0-$27.7M$-6.40
Get Your Daily Market Recap